Pathology

Pathology/C/69

Tumors of the urinary bladder and collecting system

膀胱・尿路上皮系の腫瘍

1. Overview

  • Tumors of the lower urinary tract are ~2× more common than renal cell carcinomas.
  • Most arise in the urinary bladder.
  • Most are derived from urothelium (transitional epithelium) lining the renal pelvis, ureters, bladder + proximal urethra.

2. Predisposing Factors

  • β-naphthylamine (aromatic amines — aniline dye, rubber, leather industries)
  • Cigarette smoking (#1 risk factor)
  • Chronic cystitis (chronic irritation — stones, catheters, Schistosoma haematobium → squamous cell carcinoma)
  • Drugs — cyclophosphamide, phenacetin
  • Genetic abnormalities (FGFR3, RAS, p53, RB)

3. Morphology

A) Benign papilloma

  • Very rare.
  • Frond-like structures with delicate fibrovascular core.
  • Covered by multilayered, well-differentiated transitional epithelium.

B) Urothelial (Transitional) Cell Carcinoma

  • Spectrum:
    • Papillary ↔ flat
    • Non-invasive ↔ invasive
    • Low-grade ↔ high-grade
  • Low-grade carcinomas:
    • Always papillary
    • Rarely invasive
    • May recur after removal
  • High-grade carcinomas:
    • Papillary or occasionally flat
    • Invasive
    • Worse prognosis

C) Carcinoma in situ (CIS)

  • Wide areas of atypical hyperplasia + dysplasia, no invasion yet.
  • Flat lesion with full-thickness atypia.

4. Tumor Types Overview

Pattern Behavior
Papilloma (benign) Very rare; well-differentiated transitional epithelium on fibrovascular core
Papillary non-invasive UC Low grade; recurs but rarely invades
Flat CIS High-grade, non-invasive; precursor to invasive carcinoma
Invasive UC Papillary or flat; poor prognosis with deep invasion

5. Clinical Course

  • Men > women, age 50–70 yr.
  • Painless hematuria — dominant clinical presentation of all bladder tumors.
  • Clinical significance depends on:
    • Histological grade
    • Differentiation
    • Depth of invasion (most important prognostic factor)
  • Ureteral/urethral orifice invasion → urinary tract obstruction → hydronephrosis.
  • Prognosis:
    • Good: low-grade non-invasive lesions.
    • Bad: deep bladder wall penetration → 5-yr survival < 20 %.

6. Other Histological Types (less common)

  • Squamous cell carcinoma — chronic irritation, Schistosoma haematobium (worldwide cause), stones, catheters.
  • Adenocarcinoma — from urachal remnant or glandular metaplasia of cystitis cystica.
  • Sarcoma botryoides (embryonal rhabdomyosarcoma) — children; grape-like mass.

💡 High-yield: Bladder cancer 2× more common than RCC. #1 type = urothelial (transitional) cell carcinoma. Risk factors: smoking (#1), β-naphthylamine, aromatic amines, cyclophosphamide, chronic cystitis (Schistosoma h. → squamous cell carcinoma). Clinical: painless hematuria in men 50–70. Low-grade papillary = recurs, rarely invades; high-grade / CIS = invasive. Prognosis depends on depth of invasion; deep → 5-yr survival <20 %.